Changing Patterns of SARS-CoV-2 Seroprevalence among Canadian Blood Donors during the Vaccine Era-Reference-Cited by-同舟云学术

Changing Patterns of SARS-CoV-2 Seroprevalence among Canadian Blood Donors during the Vaccine Era

Published:2022-04-27 Issue:2 Volume:10 Page:
ISSN:2165-0497
Container-title:Microbiology Spectrum
language:en
Short-container-title:Microbiol Spectr

Author:

Reedman Cassandra N.¹,Drews Steven J.²³^ORCID,Yi Qi-Long¹⁴,Pambrun Chantale⁵⁶,O’Brien Sheila F.¹⁴^ORCID

Affiliation:

1. Epidemiology and Surveillance, Canadian Blood Services, Ottawa, Ontario, Canada

2. Medical Microbiology Department, Canadian Blood Services Edmonton, Edmonton, Alberta, Canada

3. Department of Laboratory Medicine & Pathology, Division of Diagnostic and Applied Microbiology, University of Alberta, Edmonton, Alberta, Canada

4. School of Epidemiology and Public Health, University of Ottawa, Ottawa, Ontario, Canada

5. Medical Affairs & Innovation, Canadian Blood Services, Ottawa, Ontario, Canada

6. Department of Pathology & Laboratory Medicine, University of Ottawa, Ottawa, Ontario, Canada

Abstract

Throughout the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic, our blood donor seroprevalence study has informed Canadian public health policy at national and provincial levels. We describe the only continuously running national seroprevalence study in Canada, which spans the full length of the pandemic and per capita is one of the largest programs in the world.

Funder

Government of Canada

Publisher

American Society for Microbiology

Subject

Infectious Diseases,Cell Biology,Microbiology (medical),Genetics,General Immunology and Microbiology,Ecology,Physiology

Link

https://journals.asm.org/doi/pdf/10.1128/spectrum.00339-22

Reference42 articles.

1. Public Health Agency of Canada (PHAC). 2021. Coronavirus disease (COVID-19): outbreak update. https://canada.ca/en/public-health/services/diseases/2019-novel-coronavirus-infection.html. Accessed January 18 2022.

2. COVID-19 in Canada

3. Are we underestimating seroprevalence of SARS-CoV-2?

4. Estimated Incidence of Coronavirus Disease 2019 (COVID-19) Illness and Hospitalization—United States, February–September 2020

5. Estimated US Infection- and Vaccine-Induced SARS-CoV-2 Seroprevalence Based on Blood Donations, July 2020-May 2021

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. SARS-CoV-2 vaccination in Canadian blood donors: Insight into donor representativeness of the general population;Vaccine: X;2024-06

2. Temporal trends in disparities in COVID-19 seropositivity among Canadian blood donors;International Journal of Epidemiology;2024-04-11

3. Reactivity of anti‐SARS‐CoV‐2 antibodies in Serbian voluntary blood donors;Transfusion Medicine;2024-04

4. SARS-CoV-2 seroprevalence in Nova Scotia blood donors;Journal of the Association of Medical Microbiology and Infectious Disease Canada;2024-03-29

5. Realistic Estimation of COVID-19 Infection by Seroprevalence Surveillance of SARS-CoV-2 Antibodies: An Experience From Korea Metropolitan Area From January to May 2022;Journal of Korean Medical Science;2024